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Malaria is caused by infection with Plasmodium parasites. Various studies with knock-
out mice have indicated that IFN-γ plays essential roles in protective immunity against
blood-stage Plasmodium infection. However, after Plasmodium infection, increased IFN-γ
production by various types of cells is involved not only in protective immunity, but also
in immunopathology. Recent reports have shown that IFN-γ acts as a pro-inflammatory
cytokine to induce not only the activation of macrophages, but also the generation of
uncommon myelolymphoid progenitor cells after Plasmodium infection. However, the
effects of IFN-γ on hematopoietic stem cells and progenitor cells are unclear.Therefore, the
regulation of hematopoiesis by IFN-γ during Plasmodium infection remains to be clarified.
Although there are conflicting reports concerning the significance of γδT cells in protective
immunity against Plasmodium infection, γδ T cells may respond to infection and produce
IFN-γ as innate immune cells in the early phase of blood-stage malaria. Our recent stud-
ies have shown that γδ T cells express CD40 ligand and produce IFN-γ after Plasmodium
infection, resulting in the enhancement of dendritic cell activation as part of the immune
response to eliminate Plasmodium parasites. These data suggest that the function of γδ
T cells is similar to that of NK cells. Although several reports suggest that γδ T cells have
the potential to act as memory cells for various infections, it remains to be determined
whether memory γδT cells are generated by Plasmodium infection and whether memory
γδ T cells can contribute to the host defense against re-infection with Plasmodium. Here,
we summarize and discuss the effects of IFN-γ and the various functions of γδ T cells in
blood-stage Plasmodium infection.
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Malaria is one of the most serious public health problems world-
wide, and the malaria-endemic areas include both tropical and
subtropical regions. Plasmodium, the malaria-causing protozoan
parasite, has a complex life cycle. Mammalian hosts, such as
humans, monkeys, and mice, are inoculated with sporozoites
into the host dermis of skin via a bite by a Plasmodium-infected
Anopheles mosquito (1). Sporozoites then enter blood stream for
invasion into hepatocytes and develop into merozoites with repli-
cation (liver-stage). Merozoites parasitize red blood cells (RBCs),
replicate, and then rupture the RBCs, allowing for new infection
of additional normal RBCs (blood-stage). In contrast to asympto-
matic liver-stage malaria, blood-stage malaria is the symptomatic
phase. Thus, protective immunity against blood-stage malaria is
important for reducing the severity of disease (Figure 1).
Infection with Plasmodium falciparum causes the most severe
malaria in humans. The predominant symptoms are anemia,
splenomegaly, and fever. Cerebral malaria, liver dysfunction, acute
renal failure, acidosis, hypoglycemia, respiratory distress, and
edema are also observed as complications in malaria patients,
although these symptoms do not always appear. Certain Plasmod-
ium species can specifically infect rodents and cause malaria. A
rodent malaria model is very useful not only for the develop-
ment of anti-malarial drugs and vaccines, but also in research
studies into the protective and pathologic immune responses dur-
ing malaria. The lethality of the Plasmodium infection is depen-
dent upon combinations of Plasmodium species and inbred mouse
strains. Here, we review experimental studies on Plasmodium
infections in the mouse and human studies with P. falciparum,
focusing on protective immunity against Plasmodium infections.
Interferon-γ (IFN-γ) is produced mainly by lymphocytes, such
as αβ T cells, natural killer (NK) cells, NKT cells, and γδ T
cells (2–5). Some myeloid cells have also been reported to have
the potential to produce IFN-γ (6–10). IFN-γ is an important
pro-inflammatory cytokine and a mediator of immune responses
against intracellular bacteria and viruses (11–14). Furthermore, it
plays a protective role against infection by protozoan parasites (15–
18). It enhances phagocyte activity, resulting in the elimination of
extracellular bacteria and protozoan parasites, and its production
by CD4+ helper T cells, CD8+ killer T cells, and NK cells is greatly
induced by IL-12 and IL-18 from antigen-presenting cells (APCs),
such as dendritic cells (DCs) (19–22). Moreover, some reports
have shown that IFN-γ production from APCs is regulated by
IL-12, IL-15, and IL-18 (23–25).
γδ T cells work as innate lymphocytes, the first line of defense
against infectious pathogens. On the other hand, αβ T cells, such
as CD4+ helper T cells and CD8+ killer T cells, are typically
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FIGURE 1 | Life cycle of Plasmodium parasites. A bite from a
Plasmodium-infected Anopheles mosquito inoculates human hosts with
sporozoites in the dermis of skin. The sporozoites move into the bloodstream,
and parasitize hepatocytes. Invaded sporozoites develop into merozoites with
replication (liver-stage). Then, merozoites are released from hepatocytes.
Merozoites parasitize red blood cells (RBCs), replicate, and then rupture the
RBCs, leading to new infection of normal RBCs (nRBCs; blood-stage).
Merozoites have several developmental phases: the ring form (early
trophozoite), trophozoite, and schizont. Furthermore, some merozoites
mature into female and male gametocytes.
related to adaptive immunity.γδT cells play critical roles in protec-
tive immune responses against protozoan parasites, bacteria, and
viruses that are associated with various infectious diseases (26–
32). This review focuses on the protective abilities of γδ T cells
and IFN-γ in the response against malaria infection.
IFN-γMEDIATES PROTECTIVE IMMUNITY AGAINST
BLOOD-STAGE PLASMODIUM PARASITES
Mice (on a C57BL/6 or CBA background) that are genetically
IFN-γ-deficient or IFN-γ receptor (IFN-γR)-deficient or that are
treated with anti-IFN-γ antibody and infected with blood-stage
P. berghei are unable to control the infecting parasite (33–35). In
the cases of infection with blood-stage P. chabaudi and P. yoelii
parasites, genetically IFN-γ-deficient or IFN-γ receptor (IFN-γR)-
deficient mice or anti-IFN-γ antibody-treated mice on a C57BL/6
or CBA background show delayed elimination of the parasites
(36–39). These experimental malaria models demonstrate that
IFN-γ is a key pro-inflammatory cytokine for controlling blood-
stage Plasmodium parasites (Table 1). IFN-γ is produced by many
cell types and involved in many steps of immune responses. αβ
T cells, NK cells, NKT cells, and γδ T cells have been shown to
produce IFN-γ after infection with Plasmodium parasites. The
contributions of producers of IFN-γ to protective immunity
against Plasmodium parasites are complicated (Figure 2). Thus,
more detailed experiments using IFN-γ signaling-deficient mod-
els should be performed to determine the mechanism(s) under-
lying the involvement of IFN-γ in immune protection against
Plasmodium parasites.
IFN-γ PRODUCERS AND THEIR ACTIVATION IN
PLASMODIUM INFECTION
CD4+ αβ T CELLS AND CD8+ αβ T CELLS
Given that MHC class II-deficient mice on a C57BL/6 background
are unable to control P. yoelii- and P. chabaudi-infected RBCs
(iRBCs), CD4+ αβ T cells respond to Plasmodium-iRBCs after
priming with malarial antigens in an MHC class II context on
DCs (40). CD4+ αβ T cells strongly increase their ability to pro-
duce IFN-γ after infection with P. berghei (32). High proportions
of CD4+ αβ T cells from P. falciparum-infected human subjects
respond to iRBCs and produce IFN-γ, compared to CD4+ αβ
T cells from naïve human subjects (4). Moreover, some studies
have shown that CD4+ αβ T cell-depleted C57BL/6 or CBA mice
treated with anti-CD4 antibody are unable to control blood-stage
P. chabaudi or P. berghei (32, 33, 41, 42). These lines of evidence
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Table 1 | Influence of IFN-γ-signal deficiency on control of Plasmodium parasites in mice.
Plasmodium strain Host mouse genotype
(mAb administration)
Mouse
background
Features of host mice after
the Plasmodium infection
Reference
P. yoelii 17XNL IFN-γ KO B6/129 Delayed elimination of parasites and had higher
parasitemia
van der Heyde et al. (37)
P. chabaudi adami 556KA IFN-γ KO B6/129 Delayed elimination of parasites and had higher
parasitemia
van der Heyde et al. (37)
P. chabaudi chabaudi AS IFN-γR KO
IFN-γ KO
B6/129
B6
Higher parasitemia during second peak. 77% of the
infected mice died Male mice developed higher
parasitemia. Female mice delayed elimination of
parasites and had higher parasitemia. 100% Male and
40% female mice died
Favre et al. (36),
Su and Stevenson (39)
P. berghei XAT WT (anti-IFN-γ mAb)
IFN-γ KO
CBA
B6
Could not eliminate parasites and died Waki et al. (33),
Yoneto et al. (35)
P. berghei NK65 WT (anti-IFN-γ mAb)
WT (anti-IFN-γ mAb)
CBA
B6
P. berghei NK65 is a high virulent strain and induces
liver injury in CBA and B6 mice. The mAb-treated mice
prolonged survival
Waki et al. (33),
Yoshimoto et al. (34)
P. berghei ANKA IFN-γR KO
IFN-γ KO
IFN-γR KO
CBA
B6
B6/129
P. berghei ANKA is a high virulent strain and induces
neurological symptoms in 129 and B6 mice. The KO
mice prolonged survival and did not developed
neurological symptoms
Amani et al. (38),
Villegas-Mendez et al. (61),
Rudin et al. (94)
IFN, interferon; IFN-γR, IFNγ receptor; mAb, monoclonal antibody.
suggest that CD4+ αβ T cells are major sources of IFN-γ and
are required for protective immunity against Plasmodium infec-
tion, resulting in complete clearance of the parasites. In contrast,
the results for Plasmodium-infected mice with CD8+ αβ T-cell
depletion are comparable to those for control mice (33, 41, 42).
Moreover, CD8+ αβ T cells from highly immunized mice may
play critical roles in protective immunity against infection with a
lethal P. yoelii strain in C57BL/6 mice (41–43), although CD8+ T
cells are not required for the resolution of primary infection with
P. chabaudi or P. yoelii parasites in C57BL/6 mice. Interestingly,
involvement of perforin molecules is only partial in protective
immunity involving CD8+ αβ T cells. IFN-γ and macrophages are
key molecular and cellular factors in protective immunity involv-
ing CD8+ αβ T cells (43). These data suggest that the role of the
CD8+ αβ T cells is redundant in relation to the role of CD4+ αβ
T cells in protective immunity in repeatedly immunized mice. A
repeat infection with Plasmodium parasites may induce CD4+ αβ
T-cell exhaustion (44). Cytokine production by T cells is inhib-
ited by this exhaustion via the signaling of inhibitory receptors,
such as PD-1 and LAG3. Since CD4+ αβ T cells are still needed
to exert protective immunity against re-infection with the Plas-
modium parasites, only partial exhaustion of CD4+ αβ T cells may
occur. Therefore, both CD4+ αβ T cells and CD8+ αβ T cells may
need to produce adequate quantities of IFN-γ to ensure clearance
of the Plasmodium parasites.
DENDRITIC CELLS
Several reports have shown that IFN-γ is also produced by DCs
(8–10). The IFN-γ-producing DCs are important for priming
lymphocytes (10), although it remains to be determined whether
IFN-γ production by DCs enhances protective immunity against
Plasmodium parasites, and whether stimulation of Toll-like recep-
tors (TLRs) by parasite components induces IFN-γ production by
DCs (45–48).
γδ T CELLS AND NK CELLS
γδ T cells and NK cells are considered to be important IFN-γ
producers in blood-stage malaria infections and to be associated
with the control of malarial parasites (2, 3, 5). In the early stages
of malaria infection, γδ T cells directly recognize the pathogen
through MHC-independent mechanisms that involve the γδTCR,
and high levels of IFN-γ production and proliferation are induced
(49–51). Several reports have suggested that proliferation of γδ T
cells depends on IL-2 (52, 53). Human and murine γδ T cells usu-
ally express TLRs, and the expression levels of TLRs are enhanced
by γδTCR stimulation (54–56). Therefore, TLR is another can-
didate receptor for γδ T-cell responses to malaria antigens (46,
57). Although studies have suggested that γδ T cells have the
potential to react to malarial antigens via TLRs, TLR signaling
in myeloid cells may be more important for the induction of
protective immunity against malaria (58).
A study of experimental P. falciparum infection showed that,
in contrast to γδ T cells, NK cells were minor IFN-γ producers in
response to iRBCs before and after P. falciparum infection (5). A
longitudinal study of children in Papua New Guinea indicated that
IFN-γ-producing responses of malaria antigen-specific γδ T cells,
but not those of NK cells, were important for protective immunity
against P. falciparum infection (59). In contrast, several in vitro
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FIGURE 2 | IFN-γ producers and their activation. CD4+ and CD8+ αβT
cells, NK cells, and γδT cells have been shown to produce IFN-γ after
infection with Plasmodium parasites. Innate immune cells can directly
recognize Plasmodium antigens. γδT cells can recognize
phosphoantigens by MHC II-independent pathways via TCRγδ, resulting
in the activation of DCs and IFN-γ production. Whether γδT cells can
recognize malarial antigens via TLR is unknown. DCs phagocytose
iRBCs and recognize malarial DNA and hemozoin or
glycosylphosphatidylinositol (GPI) anchors via TLRs, resulting in the
activation of DCs. DCs are thought to have the potential to produce
IFN-γ. However, it remains unclear as to whether IFN-γ production from
DCs is induced by malarial antigens. Activated DCs produce IL-12 and
present antigens to αβT cells. αβT cells are strongly activated by IL-12
and antigen presentation. IL-12 also activates NK cells. The malarial
antigen-recognition receptor on NK cells remains to be determined.
Activation of αβT cells leads to high IFN-γ production. Furthermore,
activated αβT cells produce IL-2, resulting in the proliferation of γδT cells
and NK cells and the αβT cells themselves.
culture studies have shown that NK cells rapidly induce IFN-γ
production in response to P. falciparum-iRBCs via IL-12 and IL-
18 signaling. These reports suggest that NK cells have the potential
to produce IFN-γ in response to P. falciparum.
IFN-γ INDUCES PATHOLOGIC EFFECTS IN SEVERE MALARIA
Interferon-γ is not only a key factor in protection against Plasmod-
ium infection, but also a pathogenicity factor in severe malaria
symptoms (33, 38, 60, 61, 94). It is well-known that P. berghei
ANKA infection leads to the development of experimental cere-
bral malaria (ECM), and P. berghei NK65 infection induces liver
injury. Those P. berghei-infected mice are useful models for studies
of severe malarial symptoms. IFN-γR-deficient mice on a C57BL/6
or 129 background do not develop ECM. Furthermore, P. berghei
NK65-infected mice on a C57BL/6 or CBA background treated
with anti-IFN-γ antibody live longer than those treated with
control-IgG. These reports suggest that IFN-γ is important for
the development of severe malarial symptoms (Table 1) (33, 34,
38, 94). ECM also does not develop in P. berghei ANKA-infected
mice after depletion of CD4+ T cells or CD8+ T cells (62). Cyto-
toxic CD8+ αβT cells, which express perforin or granzyme B, have
important roles in the development of ECM (63, 64). Although
both CD4+ αβ T and CD8+ αβ T cells have a similar potential to
produce IFN-γ, CD8+ αβ T cells are not an important IFN-γ pro-
ducer for the development of ECM (61). IFN-γ-producing CD4+
αβT cells promote recruitment of cytotoxic CD8+ αβT cells to the
brain; in contrast, CD4+ αβ T cells dot not accumulate markedly
in the brain (60). Because depletion of NK cells can prevent ECM
after infection with P. berghei ANKA, NK cells are also associated
with IFN-γ responses in the development of ECM. NK cells acti-
vate CD8α+ DCs that prime CD8+ αβ T cells after infection with
P. berghei ANKA (65). Furthermore, depletion of γδ T cells can
also prevent ECM after infection with P. berghei ANKA. Therefore
γδ T cells would be also associated with IFN-γ responses in the
development of ECM (66). IFN-γ has both protective and patho-
logic effects on the immune response to Plasmodium infections.
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Therefore, simply inducing a reduction in blood IFN-γ levels by
treatment with an antibody or drug may not be an effective way
to treat cerebral malaria. Further studies focused on the regula-
tion of CD8+ αβ T-cell activation by DCs are needed to develop a
preventative therapy for cerebral malaria.
DOES IFN-γ INDUCE EFFECTIVE HEMATOPOIESIS IN THE
HOST?
IFN-γ is an important mediator of hematopoietic stem cell and
progenitor cell activation during bacterial infections (67–69). Fur-
thermore, rodent Plasmodium infection induces the generation of
uncommon myelolymphoid progenitor cells, which express IL7-
R+ and c-Kithi via IFN-γ signaling. These myelolymphoid prog-
enitor cells can differentiate into both myeloid cells and lymphoid
cells (70). Host protection from malaria depends on hematopoietic
differentiation (i.e., hematopoiesis) to supply many types of dif-
ferentiated cells. First, differentiation of erythroid progenitor cells
is necessary to avoid the development of severe anemia. Second,
differentiation of myeloid progenitor cells is necessary to supply
a high number of phagocytic cells for the clearance of Plasmod-
ium parasites. Hematopoiesis is a fundamental process for“curing”
malaria and other infections. Moreover, several studies have shown
IFN-γ-induced inhibition of some steps of hematopoiesis (71–
73). Considering important roles of IFN-γ in protective immunity
against Plasmodium parasites, IFN-γ would be a key factor for reg-
ulation of effective hematopoiesis in malaria. There are many cell
types of IFN-γ producers in Plasmodium infection as mentioned
above. Therefore, some of the IFN-γ producers in Plasmodium
infection may play crucial role for regulation of hematopoiesis by
the effect of IFN-γ or a combination of IFN-γ and other factors,
which are produced from the IFN-γ-producing cells.
HOST IMMUNE RESPONSES OF γδ T CELLS IN MALARIA
VARIETIES OF γδ T-CELL FUNCTION
γδ T cells play various roles, including in protective immunity
against pathogens, in the curing of injured tissue, tumor surveil-
lance, and as a bridge between innate and adaptive immunity.
These multiple functions of γδ T cells are thought to be due to
their abilities to produce various cytokines and chemokines. Such
abilities are broadly restricted by the Vγ and Vδ repertoires of
γδ T cells. The distribution of γδ T-cell subsets differs depending
on their resident tissue (74). To examine the physiologic role(s)
in the immune response against Plasmodium parasites, γδ T-cell
subsets should be compared carefully between mice and humans
based on their abilities, such as cytokine production or ligands for
activation.
γδ T-CELL-RELATED PROTECTIVE IMMUNITY AGAINST BLOOD-STAGE
PLASMODIUM INFECTION
Although previous reports of in vitro and in vivo experiments have
suggested that γδ T cells are associated with protective immune
responses during malaria infection, the functions of γδ T cells in
the spleen remain largely unknown (75–79). We recently reported
on the mechanism of γδT-cell-related protective immunity against
Plasmodium parasites using the rodent malaria parasite P. berghei
XAT (32, 80) (Figure 3). P. berghei XAT is an attenuated strain
derived from the lethal P. berghei NK65 strain (32, 81). P. berghei
FIGURE 3 | γδT-cell-related protective immunity. γδT cells and DCs are
activated by Plasmodium infection. Activated γδT cells begin to express
CD40L and produce IFN-γ. The activated γδT cells enhance MHC II and
co-stimulatory factors on DCs, and induce high levels of IL-12 production
from DCs. The CD40L-expressing γδT cells enhance DC activation.
Activated DCs induce differentiation of naïve CD4+ T cells into
IFN-γ-producing TH1 cells.
XAT was developed for investigations of vaccines and protec-
tive immune responses against Plasmodium parasites owing to its
potent ability to induce immune memory, even against lethal P.
berghei NK65 strains. Previous studies have reported the essential
cytokines and immune cells required for the clearance of P. berghei
XAT. Since γδ T-cell-deficient mice on a C57BL/6 background are
unable to control P. berghei XAT infection, γδ T cells are essential
for protective immunity against the parasites (32). Other stud-
ies using P. chabaudi parasites have also suggested that γδ T cells
are related to, but not essential for, protective immunity against
the parasites (76, 78). Thus, this P. berghei XAT strain is useful
for investigating the mechanism(s) of γδ T-cell-related protective
immunity against Plasmodium parasites. In general, the immuno-
logic functions of γδ T cells are largely similar to those of NK
cells. The difference in the need for γδ T cells between protective
immunity against the two parasite strains may be influenced by
the contribution of NK cells to protective immunity.
Although malaria infections in humans, monkeys, and mice
lead to increased numbers of γδ T cells in the blood and spleen,
the γδ T-cell population is still minor in relation to the total num-
ber of lymphocytes (82). It may be possible to explain why such
a minor population of lymphocytes plays such key roles in pro-
tective immunity against malaria parasites. First, γδ T cells can
directly recognize malarial parasites, making them major produc-
ers of IFN-γ in response to malaria antigens during the early phase
of infection. In contrast, NK cells are reciprocally regulated by
DCs. Thus, DC activation is needed first to activate NK cells in
malaria infection (3, 83). NK cells are unexpectedly minor pro-
ducers of IFN-γ in response to malarial antigens in human blood
in experimental infections with P. falciparum parasites (59). Nev-
ertheless, NK cells also become key players in protective immunity
against malarial parasites, as has been shown in many studies (2,
3, 83), although NK cells are not required for the control of P.
berghei XAT parasites (35). Second, γδ T cells have the ability to
interact readily with other central immune players, such as DCs.
Our recent report showed that about 30% of splenic γδ T cells
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were localized in the vicinity of DCs even under naïve conditions.
A more than twofold increase in the percentage of splenic γδ T
cells that adhered to DCs was observed in the early phase of infec-
tion (32). The molecular mechanism of this adhesive ability of
γδ T cells to DCs remains to be determined. As γδ T cells can
produce chemokines, some γδ T-cell-produced chemokines may
attract DCs and also αβ T cells to help antigen presentation by
DCs (84, 85). Furthermore, our study provided evidence that γδ
T cells boost DC activation for protective immunity against P.
berghei XAT parasites via CD40 ligand expression on γδ T cells.
CD40L-CD40 signaling induces the expression of MHC II and co-
stimulatory factors, such as CD40, CD80, and CD86 (32). Such
signaling to DCs would be synergistically activated by the uptake
of Plasmodium antigens (86).
MEMORY PHENOTYPE OF γδ T CELLS IN MALARIA
For long-standing protective immunity against pathogens, mem-
ory lymphocytes maintain phenotypes to respond against
pathogens and live for a long period after infections or vacci-
nation with antigens (87, 88). In general, memory T cells are
converted from naïve T cells through three phases (expansion,
contraction, and memory phases; Figure 4). In the expansion
phase, effector or killer T cells activate and proliferate after patho-
logic infection. Soon after pathogen clearance, the numbers of
expanded antigen-specific T cells are reduced by induction of
apoptosis in the contraction phase. Then, a fraction of the remain-
ing antigen-specific T cells become memory T cells, resulting in
long-lasting and rapid protective immunity against re-infection
with pathogens (memory phase). Memory plasma cells and B cells
maintain the potential to generate antigen-specific antibodies, and
memory CD4+ T cells and CD8+ T cells maintain rapid helper
and killer responses to antigens, resulting in rapid elimination of
re-infecting pathogens. In malaria, those memory lymphocytes
would also exist in human subjects who have been infected with
Plasmodium parasites previously (4, 5). However, there is still con-
troversy over the duration of memory lymphocyte maintenance
(89, 90). Previous studies have shown that human γδ T cells gen-
erate rapid and amplified responses to a secondary challenge of
bacteria and viruses, such as mycobacteria and cytomegalovirus
(91, 92). These data suggest that human γδ T cells have the ability
to develop memory cells for protection against re-infection. On
the other hand, a recent report suggested that human γδ T cells
develop effector memory cells after infection with P. falciparum
parasites (5).
Some details about memory γδ T cells in malaria remain to
be uncovered (Figure 4). The first point is the importance of
memory γδ T cells in malaria. Although the numbers of malaria
antigen-specific γδ T cells certainly increase in the year after pri-
mary infection, whether the memory γδ T cells are important for
effective protection against re-infection with Plasmodium parasites
remains to be determined. The second point is the developmen-
tal process of memory γδ T cells. γδ T cells function not only in
adaptive immunity but also in innate immunity. Thus, the process
for the development of memory γδ T cells may differ from that
of general memory T cells in malaria or in other infections. The
third point is the localization of memory γδT cells. A recent report
showed that memory T cells in lymph nodes and peripheral tissues
FIGURE 4 | Memory γδT cells. Naïve T cells are activated by pathologic
infections and differentiate into effector or killer T cells. Activated T cells
clonally expand in response to particular antigens (expansion phase). After
pathogen clearance, high proportions of the expanded antigen-specific T
cells undergo apoptosis (contraction phase). Some population of the
surviving antigen-specific T cells is maintained as memory T cells (memory
phase). γδT cells also expand after infection with pathogens, including
Plasmodium parasites. High-level proliferation of γδT cells is involved in
generating IL-2 from TH1 cells or the γδT cells themselves. It remains to be
determined whether antigen-specific γδT cells shift into a contraction
phase and then a memory phase.
translocate to bone marrow for the long term (93). It would be dif-
ficult to examine whether this hypothesis applies to memory γδ T
cells, and other memory lymphocytes, in human subjects. Thus,
rodent malaria models are needed for examining the location of
memory γδ T cells.
CONCLUDING REMARKS
Many studies have demonstrated that IFN-γ is responsible for
protective immunity against Plasmodium parasites. The critical
cellular source(s) of IFN-γ in malaria patients remains to be deter-
mined. γδ T cells are not only a major candidate as the key IFN-γ
producer, but are also critical modulators of protective immunity
against Plasmodium parasites. We should continue to investigate
the roles of γδ T cells in host defenses against Plasmodium par-
asites. Thus, it is important to investigate whether the abilities
of γδ T cells to produce IFN-γ and mediate immune responses
against malarial antigens persist as memory cells. Mechanisms of
immune responses in lymphoid tissues, especially in the spleen,
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to blood-stage malaria are gradually being uncovered by studies
using rodent malaria models. To investigate further the relation-
ship between IFN-γ and γδ T cells in immune responses against
malaria, we should make more effort to study the issues using not
only rodent malaria models, but also humanized mice that can be
infected with P. falciparum parasites. To make this a reality, we
first need to refine the humanized mice. Based on studies of γδ T-
cell-related protective immunity, we may be able to develop novel
strategies for a malaria vaccine.
ACKNOWLEDGMENTS
This work was supported by the Moritani Scholarship Foundation,
the Japan Prize Foundation to Shin-Ichi Inoue. This work was also
supported by Grants-in-Aid for Young Scientists (B) to Shin-Ichi
Inoue (No. 23790462) and Mamoru Niikura (No. 24790405) and
a Grant-in-Aid for Scientific Research (C) to Fumie Kobayashi
(No. 23590493) from the Japan Society for the Promotion of Sci-
ence (JSPS). We thank Mrs. Natsuki Yokota for her support of our
work.
REFERENCES
1. Amino R,Thiberge S,Martin B,Celli
S, Shorte S, Frischknecht F, et al.
Quantitative imaging of Plasmod-
ium transmission from mosquito to
mammal. Nat Med (2006) 12:220–
4. doi:10.1038/nm1350
2. Artavanis-Tsakonas K, Riley EM.
Innate immune response to malaria:
rapid induction of IFN-γ from
human NK cells by live Plasmodium
falciparum-infected erythrocytes. J
Immunol (2002) 169:2956–63.
3. Ing R, Stevenson MM. Dendritic
cell and NK cell reciprocal cross
talk promotes gamma interferon-
dependent immunity to blood-stage
Plasmodium chabaudi AS infec-
tion in mice. Infect Immun (2009)
77:770–82. doi:10.1128/IAI.00994-
08
4. Roestenberg M, McCall M, Hopman
J, Wiersma J, Luty AJ, van Gemert
GJ,et al. Protection against a malaria
challenge by sporozoite inoculation.
N Engl J Med (2009) 361:468–77.
doi:10.1056/NEJMoa0805832
5. Teirlinck AC, McCall MB, Roesten-
berg M, Scholzen A, Woestenenk
R, de Mast Q, et al. Longevity and
composition of cellular immune
responses following experimen-
tal Plasmodium falciparum malaria
infection in humans. PLoS Pathog
(2011) 7:e1002389. doi:10.1371/
journal.ppat.1002389
6. Flesch IE, Hess JH, Huang S, Aguet
M, Rothe J, Bluethmann H, et
al. Early interleukin 12 produc-
tion by macrophages in response to
mycobacterial infection depends on
interferon γ and tumor necrosis fac-
tor α. J Exp Med (1995) 181:1615–
21. doi:10.1084/jem.181.5.1615
7. Hilkens CM, Kalinski P, de Boer M,
Kapsenberg ML. Human dendritic
cells require exogenous interleukin-
12-inducing factors to direct the
development of naive T-helper cells
toward the Th1 phenotype. Blood
(1997) 90:1920–6.
8. Ohteki T, Fukao T, Suzue K,
Maki C, Ito M, Nakamura M, et
al. Interleukin 12-dependent inter-
feron γ production by CD8α+
lymphoid dendritic cells. J Exp
Med (1999) 189:1981–6. doi:10.
1084/jem.189.12.1981
9. Suzue K, Asai T, Takeuchi T, Koy-
asu S. In vivo role of IFN-γ pro-
duced by antigen-presenting cells
in early host defense against intra-
cellular pathogens. Eur J Immunol
(2003) 33:2666–75. doi:10.1002/eji.
200323292
10. Moretto MM,Weiss LM, Combe CL,
Khan IA. IFN-γ-producing den-
dritic cells are important for prim-
ing of gut intraepithelial lympho-
cyte response against intracellu-
lar parasitic infection. J Immunol
(2007) 179:2485–92.
11. Buchmeier NA, Schreiber RD.
Requirement of endogenous
interferon-γ production for resolu-
tion of Listeria monocytogenes infec-
tion. Proc Natl Acad Sci U S A (1985)
82:7404–8. doi:10.1073/pnas.82.21.
7404
12. Huang S, Hendriks W, Althage A,
Hemmi S, Bluethmann H, Kamijo
R, et al. Immune response in mice
that lack the interferon-γ receptor.
Science (1993) 259:1742–5. doi:10.
1126/science.8456301
13. Kim BH, Shenoy AR, Kumar P,
Das R, Tiwari S, MacMicking JD.
A family of IFN-γ-inducible 65-kD
GTPases protects against bacterial
infection. Science (2011) 332:717–
21. doi:10.1126/science.1201711
14. Green AM, Difazio R, Flynn JL. IFN-
γ from CD4 T cells is essential for
host survival and enhances CD8
T cell function during Mycobac-
terium tuberculosis infection. J
Immunol (2013) 190:270–7. doi:10.
4049/jimmunol.1200061
15. Murray HW, Rubin BY, Rother-
mel CD. Killing of intracel-
lular Leishmania donovani by
lymphokine-stimulated human
mononuclear phagocytes. Evidence
that interferon-γ is the activating
lymphokine. J Clin Invest (1983)
72:1506–10. doi:10.1172/JCI110972
16. Torrico F, Heremans H, Rivera
MT, Van ME, Billiau A, Carlier
Y. Endogenous IFN-γ is required
for resistance to acute Trypanosoma
cruzi infection in mice. J Immunol
(1991) 146:3626–32.
17. Scharton-Kersten TM, Wynn TA,
Denkers EY, Bala S, Grunvald E,
Hieny S, et al. In the absence of
endogenous IFN-γ, mice develop
unimpaired IL-12 responses to Tox-
oplasma gondii while failing to con-
trol acute infection. J Immunol
(1996) 157:4045–54.
18. Yamamoto M, Okuyama M, Ma
JS, Kimura T, Kamiyama N, Saiga
H, et al. A cluster of interferon-γ-
inducible p65 GTPases plays a criti-
cal role in host defense against Tox-
oplasma gondii. Immunity (2012)
37:302–13. doi:10.1016/j.immuni.
2012.06.009
19. Micallef MJ, Ohtsuki T, Kohno
K, Tanabe F, Ushio S, Namba
M, et al. Interferon-γ-inducing
factor enhances T helper 1
cytokine production. Eur J
Immunol (1996) 26:1647–51.
doi:10.1002/eji.1830260736
20. Takeda K, Tsutsui H, Yoshimoto
T, Adachi O, Yoshida N, Kishi-
moto T, et al. Defective NK
cell activity and Th1 response
in IL-18-deficient mice. Immu-
nity (1998) 8:383–90. doi:10.1016/
S1074-7613(00)80543-9
21. Okamoto I, Kohno K, Tanimoto T,
Ikegami H, Kurimoto M. Develop-
ment of CD8+ effector T cells is dif-
ferentially regulated by IL-18 and
IL-12. J Immunol (1999) 162:3202–
11.
22. Kamath AT, Sheasby CE, Tough DF.
Dendritic cells and NK cells stim-
ulate bystander T cell activation in
response to TLR agonists through
secretion of IFN-αβ and IFN-γ. J
Immunol (2005) 174:767–76.
23. Munder M, Mallo M, Eichmann K,
Modolell M. Murine macrophages
secrete interferon-γupon combined
stimulation with interleukin (IL)-
12 and IL-18: a novel pathway of
autocrine macrophage activation. J
Exp Med (1998) 187:2103–8. doi:10.
1084/jem.187.12.2103
24. Otani T, Nakamura S, Toki M,
Motoda R, Kurimoto M, Orita K.
Identification of IFN-γ-producing
cells in IL-12/IL-18-treated mice.
Cell Immunol (1999) 198:111–9.
doi:10.1006/cimm.1999.1589
25. Fricke I, Mitchell D, Mittelstädt J,
Lehan N, Heine H, Goldmann T,
et al. Mycobacteria induce IFN-γ
production in human dendritic cells
via triggering of TLR2. J Immunol
(2006) 176:5173–82.
26. Hiromatsu K, Yoshikai Y, Matsuzaki
G,Ohga S,Muramori K,Matsumoto
K, et al. A protective role of γδT cells
in primary infection with Listeria
monocytogenes in mice. J Exp Med
(1992) 175:49–56. doi:10.1084/jem.
175.1.49
27. Rosat JP, MacDonald HR, Louis JA.
A role for γδ T cells during experi-
mental infection of mice with Leish-
mania major. J Immunol (1993)
150:550–5.
28. Hisaeda H, Nagasawa H, Maeda K,
Maekawa Y, Ishikawa H, Ito Y, et al.
γδ T cells play an important role
in hsp65 expression and in acquir-
ing protective immune responses
against infection with Toxoplasma
gondii. J Immunol (1995) 155:
244–51.
29. Wang T, Gao Y, Scully E, Davis CT,
Anderson JF, Welte T, et al. γδ T cells
facilitate adaptive immunity against
West Nile virus infection in mice. J
Immunol (2006) 177:1825–32.
30. Déchanet J, Merville P, Lim A,
Retière C, Pitard V, Lafarge X,
et al. Implication of γδ T cells
in the human immune response
to cytomegalovirus. J Clin Invest
(1999) 103:1437–49. doi:10.1172/
JCI5409
31. Egan CE, Dalton JE, Andrew EM,
Smith JE, Gubbels MJ, Striepen
B, et al. A requirement for the
Vγ1+ subset of peripheral γδ
T cells in the control of the
systemic growth of Toxoplasma
gondii and infection-induced
pathology. J Immunol (2005) 175:
8191–9.
32. Inoue S, Niikura M, Takeo S, Mineo
S, Kawakami Y, Uchida A, et al.
Enhancement of dendritic cell acti-
vation via CD40 ligand-expressing
γδ T cells is responsible for protec-
tive immunity to Plasmodium par-
asites. Proc Natl Acad Sci U S A
(2012) 109:12129–34. doi:10.1073/
pnas.1204480109
www.frontiersin.org August 2013 | Volume 4 | Article 258 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inoue et al. IFN-γ and γδT cells in malaria
33. Waki S, Uehara S, Kanbe K, Ono K,
Suzuki M, Nariuchi H. The role of
T cells in pathogenesis and protec-
tive immunity to murine malaria.
Immunology (1992) 75:646–51.
34. Yoshimoto T, Takahama Y, Wang
CR, Yoneto T, Waki S, Nariuchi
H. A pathogenic role of IL-12 in
blood-stage murine malaria lethal
strain Plasmodium berghei NK65
infection. J Immunol (1998) 160:
5500–5.
35. Yoneto T, Yoshimoto T, Wang CR,
Takahama Y, Tsuji M, Waki S, et
al. Gamma interferon production
is critical for protective immunity
to infection with blood-stage Plas-
modium berghei XAT but neither
NO production nor NK cell activa-
tion is critical. Infect Immun (1999)
67:2349–56.
36. Favre N, Ryffel B, Bordmann G,
Rudin W. The course of Plasmod-
ium chabaudi chabaudi infections
in interferon-γ receptor deficient
mice. Parasite Immunol (1997)
19:375–83. doi:10.1046/j.1365-
3024.1997.d01-227.x
37. van der Heyde HC, Pepper B,
Batchelder J, Cigel F, Weidanz WP.
The time course of selected malar-
ial infections in cytokine-deficient
mice. Exp Parasitol (1997) 85:206–
13. doi:10.1006/expr.1996.4132
38. Amani V, Vigário AM, Belnoue E,
Marussig M, Fonseca L, Mazier
D, et al. Involvement of IFN-γ
receptor-medicated signaling in
pathology and anti-malarial immu-
nity induced by Plasmodium berghei
infection. Eur J Immunol (2000)
30:1646–55. doi:10.1002/1521-
4141(200006)30:6<1646::AID-
IMMU1646>3.0.CO;2-0
39. Su Z, Stevenson MM. Central
role of endogenous γ interferon
in protective immunity against
blood-stage Plasmodium chabaudi
AS infection. Infect Immun (2000)
68:4399–406. doi:10.1128/IAI.68.8.
4399-4406.2000
40. Cigel F, Batchelder J, Burns JM Jr,
Yañez D, van der Heyde H, Man-
ning DD, et al. Immunity to blood-
stage murine malarial parasites is
MHC class II dependent. Immunol
Lett (2003) 89:243–9. doi:10.1016/
S0165-2478(03)00152-4
41. Süss G, Eichmann K, Kury E, Linke
A, Langhorne J. Roles of CD4-
and CD8-bearing T lymphocytes
in the immune response to the
erythrocytic stages of Plasmodium
chabaudi. Infect Immunity (1988)
56:3081–8.
42. Podoba JE, Stevenson MM. CD4+
and CD8+ T lymphocytes both con-
tribute to acquired immunity to
blood-stage Plasmodium chabaudi
AS. Infect Immun (1991) 59:51–8.
43. Imai T, Shen J, Chou B, Duan X,
Tu L, Tetsutani K, et al. Involve-
ment of CD8+ T cells in protective
immunity against murine blood-
stage infection with Plasmodium
yoelii 17XL strain. Eur J Immunol
(2010) 40:1053–61. doi:10.1002/eji.
200939525
44. Butler NS, Moebius J, Pewe LL, Tra-
ore B, Doumbo OK, Tygrett LT, et al.
Therapeutic blockade of PD-L1 and
LAG-3 rapidly clears established
blood-stage Plasmodium infection.
Nat Immunol (2011) 13(2):188–95.
doi:10.1038/ni.2180
45. Coban C, Ishii KJ, Kawai T, Hemmi
H, Sato S, Uematsu S, et al. Toll-
like receptor 9 mediates innate
immune activation by the malaria
pigment hemozoin. J Exp Med
(2005) 201:19–25. doi:10.1084/jem.
20041836
46. Parroche P, Lauw FN, Goutagny
N, Latz E, Monks BG, Visintin
A, et al. Malaria hemozoin is
immunologically inert but radically
enhances innate responses by pre-
senting malaria DNA to Toll-like
receptor 9. Proc Natl Acad Sci U S
A (2007) 104:1919–24. doi:10.1073/
pnas.0608745104
47. Seixas E, Moura Nunes JF,
Matos I, Coutinho A. The
interaction between DC and
Plasmodium berghei/chabaudi-
infected erythrocytes in mice
involves direct cell-to-cell contact,
internalization and TLR. Eur J
Immunol (2009) 39:1850–63.
doi:10.1002/eji.200838403
48. Gowda NM, Wu X, Gowda DC.
TLR9 and MyD88 are crucial
for the development of protective
immunity to malaria. J Immunol
(2012) 188:5073–85. doi:10.4049/
jimmunol.1102143
49. Morita CT, Beckman EM, Bukowski
JF, Tanaka Y, Band H, Bloom BR,
et al. Direct presentation of non-
peptide prenyl pyrophosphate anti-
gens to human γδ T cells. Immu-
nity (1995) 3:495–507. doi:10.1016/
1074-7613(95)90178-7
50. Behr C, Poupot R, Peyrat MA,
Poquet Y, Constant P, Dubois P, et al.
Plasmodium falciparum stimuli for
humanγδT cells are related to phos-
phorylated antigens of mycobac-
teria. Infect Immun (1996) 64:
2892–6.
51. Pichyangkul S, Saengkrai P, Yong-
vanitchit K, Stewart A, Heppner
DG. Activation of γδ T cells in
malaria: interaction of cytokines
and a schizont-associated Plasmod-
ium falciparum antigen. J Infect Dis
(1997) 176:233–41. doi:10.1086/
514029
52. Elloso MM, van der Heyde HC,
Troutt A, Manning DD, Weidanz
WP. Human γδ T cell subset-
proliferative response to malarial
antigen in vitro depends on CD4+
T cells or cytokines that signal
through components of the IL-2R.
J Immunol (1996) 157:2096–102.
53. Ribot JC, Debarros A, Mancio-
Silva L, Pamplona A, Silva-Santos
B. B7-CD28 costimulatory signals
control the survival and prolifer-
ation of murine and human γδ
T cells via IL-2 production. J
Immunol (2012) 189:1202–8. doi:
10.4049/jimmunol.1200268
54. Mokuno Y, Matsuguchi T, Takano
M, Nishimura H, Washizu J, Ogawa
T, et al. Expression of toll-like recep-
tor 2 on γδ T cells bearing invariant
Vγ6/Vδ1 induced by Escherichia coli
infection in mice. J Immunol (2000)
165:931–40.
55. Deetz CO, Hebbeler AM, Propp
NA, Cairo C, Tikhonov I, Pauza
CD. Gamma interferon secretion
by human Vγ2Vδ2 T cells after
stimulation with antibody against
the T-cell receptor plus the toll-like
receptor 2 agonist Pam3Cys. Infect
Immun (2006) 74:4505–11. doi:10.
1128/IAI.00088-06
56. Pietschmann K, Beetz S, Welte S,
Martens I, Gruen J, Oberg HH,
et al. Toll-like receptor expres-
sion and function in subsets of
human γδ T lymphocytes. Scand J
Immunol (2009) 70:245–55. doi:10.
1111/j.1365-3083.2009.02290.x
57. Naik RS, Branch OH, Woods AS,
Vijaykumar M, Perkins DJ, Nahlen
BL, et al. Glycosylphosphatidylinos-
itol anchors of Plasmodium fal-
ciparum: molecular characteriza-
tion and naturally elicited antibody
response that may provide immu-
nity to malaria pathogenesis. J Exp
Med (2000) 192:1563–76. doi:10.
1084/jem.192.11.1563
58. Devilder MC, Allain S, Dousset C,
Bonneville M, Scotet E. Early trig-
gering of exclusive IFN-γ responses
of human Vγ9Vδ2 T cells by TLR-
activated myeloid and plasmacy-
toid dendritic cells. J Immunol
(2009) 183:3625–33. doi:10.4049/
jimmunol.0901571
59. D’Ombrain MC, Robinson LJ,
Stanisic DI, Taraika J, Bernard N,
Michon P, et al. Association of
early interferon-gamma production
with immunity to clinical malaria:
a longitudinal study among Papua
New Guinean children. Clin Infect
Dis (2008) 47:1380–7. doi:10.1086/
592971
60. Belnoue E, Kayibanda M, Vigario
AM, Deschemin JC, van Rooijen N,
Viguier M, et al. On the patho-
genic role of brain-sequestered αβ
CD8+ T cells in experimental cere-
bral malaria. J Immunol (2002)
169:6369–75.
61. Villegas-Mendez A, Greig R, Shaw
TN, de Souza JB, Gwyer Find-
lay E, Stumhofer JS, et al. IFN-γ-
producing CD4+ T cells promote
experimental cerebral malaria by
modulating CD8+ T cell accumu-
lation within the brain. J Immunol
(2012) 189:968–79. doi:10.4049/
jimmunol.1200688
62. Yañez DM, Manning DD, Cooley
AJ, Weidanz WP, van der Heyde
HC. Participation of lymphocyte
subpopulations in the pathogene-
sis of experimental murine cere-
bral malaria. J Immunol (1996)
157:1620–4.
63. Nitcheu J, Bonduelle O, Com-
badiere C, Tefit M, Seilhean D,
Mazier D, et al. Perforin-dependent
brain-infiltrating cytotoxic CD8+ T
lymphocytes mediate experimen-
tal cerebral malaria pathogenesis. J
Immunol (2003) 170:2221–8.
64. Haque A, Best SE, Unosson K,
Amante FH, de Labastida F, Anstey
NM, et al. Granzyme B expres-
sion by CD8+ T cells is required
for the development of experimen-
tal cerebral malaria. J Immunol
(2011) 186:6148–56. doi:10.4049/
jimmunol.1003955
65. Lundie RJ, de Koning-Ward TF,
Davey GM, Nie CQ, Hansen DS,
Lau LS, et al. Blood-stage Plasmod-
ium infection induces CD8+ T lym-
phocytes to parasite-expressed anti-
gens, largely regulated by CD8α+
dendritic cells. Proc Natl Acad Sci
U S A (2008) 105:14509–14. doi:10.
1073/pnas.0806727105
66. Yañez DM, Batchelder J, van der
Heyde HC, Manning DD, Wei-
danz WP. γδ T-cell function in
pathogenesis of cerebral malaria
in mice infected with Plasmodium
berghei ANKA. Infect Immun (1999)
67:446–8.
67. Baldridge MT, King KY, Boles
NC, Weksberg DC, Goodell MA.
Quiescent haematopoietic stem
cells are activated by IFN-γ
in response to chronic infec-
tion. Nature (2010) 465:793–7.
doi:10.1038/nature09135
68. Katherine C, MacNamara KC,
Oduro K, Martin O, Jones DD,
McLaughlin M, et al. Infection-
induced myelopoiesis during
intracellular bacterial infection is
critically dependent upon IFN-γ
signaling. J Immunol (2011) 186:
Frontiers in Immunology | Immunotherapies and Vaccines August 2013 | Volume 4 | Article 258 | 8
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inoue et al. IFN-γ and γδT cells in malaria
1032–43. doi:10.4049/jimmunol.
1001893
69. MacNamara KC, Jones M, Mar-
tin O, Winslow GM. Transient
activation of hematopoietic stem
and progenitor cells by IFNγ dur-
ing acute bacterial infection. PLoS
ONE (2011) 6:e28669. doi:10.1371/
journal.pone.0028669
70. Belyaev NN, Brown DE, Diaz AI,
Rae A, Jarra W, Thompson J, et
al. Induction of an IL7-R+c-Kithi
myelolymphoid progenitor criti-
cally dependent on IFN-γ signaling
during acute malaria. Nat Immunol
(2010) 11:477–85. doi:10.1038/ni.
1869
71. Sato T, Selleri C, Young NS,
MacIejewski JP. Hematopoietic
inhibition by interferon-γ is par-
tially mediated through interferon
regulatory factor-1. Blood (1995)
86:3373–80.
72. de Bruin AM, Buitenhuis M, van
der Sluijs KF, van Gisbergen KP,
Boon L, Nolte MA. Eosinophil
differentiation in the bone marrow
is inhibited by T cell-derived
IFN-γ. Blood (2010) 116:2559–69.
doi:10.1182/blood-2009-12-
261339
73. Libregts SF, Gutiérrez L, de Bruin
AM, Wensveen FM, Papadopoulos
P, van Ijcken W, et al. Chronic IFN-
γ production in mice induces ane-
mia by reducing erythrocyte life
span and inhibiting erythropoiesis
through an IRF-1/PU.1 axis. Blood
(2011) 118:2578–88. doi:10.1182/
blood-2010-10-315218
74. Falini B, Flenghi L, Pileri S, Pelicci
P, Fagioli M, Martelli MF, et al. Dis-
tribution of T cells bearing differ-
ent forms of the T cell receptor
gamma/delta in normal and patho-
logical human tissues. J Immunol
(1989) 143:2480–8.
75. van der Heyde HC, Elloso MM,
Chang WL, Kaplan M, Manning
DD,Weidanz WP.γδT cells function
in cell-mediated immunity to acute
blood-stage Plasmodium chabaudi
adami malaria. J Immunol (1995)
154:3985–90.
76. Seixas EM, Langhorne J. γδ T
cells contribute to control of
chronic parasitemia in Plasmod-
ium chabaudi infections in mice. J
Immunol (1999) 162:2837–41.
77. Bakir HY, Tomiyama-Miyaji C,
Watanabe H, Nagura T, Kawamura
T, Sekikawa H, et al. Reasons why
DBA/2 mice are resistant to malaria
infection; expansion of CD3int
B220+ γδ T cells with double-
negative CD4-CD8-phenotype
in the liver. Immunology (2006)
117:127–35. doi:10.1111/j.1365-
2567.2005.02273.x
78. Weidanz WP, LaFleur G, Brown
A, Burns JM Jr, Gramaglia I, van
der Heyde HC. γδ T cells but
not NK cells are essential for cell-
mediated immunity against Plas-
modium chabaudi malaria. Infect
Immun (2010) 78:4331–40. doi:10.
1128/IAI.00539-10
79. Costa G, Loizon S, Guenot M,
Mocan I, Halary F, de Saint-Basile
G, et al. Control of Plasmodium
falciparum erythrocytic cycle: γδ
T cells target the red blood cell-
invasive merozoites. Blood (2011)
118:6952–62. doi:10.1182/blood-
2011-08-376111
80. Kobayashi F, Niikura M, Waki S,
Matsui T, Fujino T, Tsuruhara T, et
al. Plasmodium berghei XAT: contri-
bution of γδ T cells to host defense
against infection with blood-stage
nonlethal malaria parasite. Exp Par-
asitol (2007) 117:368–75. doi:10.
1016/j.exppara.2007.05.002
81. Waki S, Tamura J, Imanaka M,
Ishikawa S, Suzuki M. Plasmod-
ium berghei: isolation and mainte-
nance of an irradiation attenuated
strain in the nude mouse. Exp Para-
sitol (1982) 53:335–40. doi:10.1016/
0014-4894(82)90076-5
82. Nakazawa S, Brown AE, Maeno
Y, Smith CD, Aikawa M. Malaria-
induced increase of splenicγδT cells
in humans, monkeys, and mice. Exp
Parasitol (1994) 79:391–8. doi:10.
1006/expr.1994.1101
83. Horowitz A, Newman KC, Evans
JH, Korbel DS, Davis DM, Riley
EM. Cross-talk between T cells
and NK cells generates rapid
effector responses to Plasmodium
falciparum-infected erythrocytes. J
Immunol (2010) 184:6043–52. doi:
10.4049/jimmunol.1000106
84. Hudspeth K, Fogli M, Correia DV,
Mikulak J, Roberto A, Della Bella
S, et al. Engagement of NKp30 on
Vδ1 T cells induces the produc-
tion of CCL3, CCL4, and CCL5
and suppresses HIV-1 replication.
Blood (2012) 119:4013–6. doi:10.
1182/blood-2011-11-390153
85. Vermijlen D, Ellis P, Langford
C, Klein A, Engel R, Willimann
K, et al. Distinct cytokine-driven
responses of activated blood γδ T
cells: insights into unconventional
T cell pleiotropy. J Immunol (2007)
178:4304–14.
86. Schulz O, Edwards AD, Schito M,
Aliberti J, Manickasingham S, Sher
A, et al. CD40 triggering of het-
erodimeric IL–12 p70 production
by dendritic cells in vivo requires
a microbial priming signal. Immu-
nity (2000) 13:453–62. doi:10.1016/
S1074-7613(00)00045-5
87. Kaech SM, Wherry EJ, Ahmed
R. Effector and memory T-cell
differentiation: implications
for vaccine development. Nat
Rev Immunol (2002) 2:251–62.
doi:10.1038/nri778
88. Kalia V, Sarkar S, Gourley TS, Rouse
BT, Ahmed R. Differentiation of
memory B and T cells. Curr Opin
Immunol (2006) 18:255–64. doi:10.
1016/j.coi.2006.03.020
89. Freitas do Rosário AP, Muxel SM,
Rodríguez-Málaga SM, Sardinha
LR, Zago CA, Castillo-Méndez SI,
et al. Gradual decline in malaria-
specific memory T cell responses
leads to failure to maintain long-
term protective immunity to Plas-
modium chabaudi AS despite persis-
tence of B cell memory and circu-
lating antibody. J Immunol (2008)
181:8344–55.
90. Stephens R, Langhorne J. Effec-
tor memory Th1 CD4 T cells
are maintained in a mouse model
of chronic malaria. PLoS Pathog
(2010) 6:e1001208. doi:10.1371/
journal.ppat.1001208
91. Shen Y, Zhou D, Qiu L, Lai X,
Simon M, Shen L, et al. Adaptive
immune response of Vγ2Vδ2 T cells
during mycobacterial infections.
Science (2002) 295:2255–8. doi:10.
1126/science.1068819
92. Pitard V, Roumanes D, Lafarge
X, Couzi L, Garrigue I, Lafon
ME, et al. Long-term expan-
sion of effector/memory Vδ2-γδ
T cells is a specific blood sig-
nature of CMV infection. Blood
(2008) 112:1317–24. doi:10.1182/
blood-2008-01-136713
93. Tokoyoda K, Zehentmeier S, Hegazy
AN, Albrecht I, Grün JR, Löhning
M, et al. Professional memory CD4+
T lymphocytes preferentially reside
and rest in the bone marrow. Immu-
nity (2009) 30:721–30. doi:10.1016/
j.immuni.2009.03.015
94. Rudin W, Favre N, Bordmann G,
Ryffel B. Interferon-γ is essen-
tial for the development of cere-
bral malaria. Eur J Immunol
(1997) 27:810–5. doi:10.1002/eji.
1830270403
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 22 March 2013; accepted: 15
August 2013; published online: 29 August
2013.
Citation: Inoue S-I, Niikura M, Mineo
S and Kobayashi F (2013) Roles
of IFN-γ and γ δ T cells in pro-
tective immunity against blood-stage
malaria. Front. Immunol. 4:258. doi:
10.3389/fimmu.2013.00258
This article was submitted to
Immunotherapies and Vaccines, a section
of the journal Frontiers in Immunology.
Copyright © 2013 Inoue, Niikura, Mineo
and Kobayashi. This is an open-access
article distributed under the terms of the
Creative Commons Attribution License
(CC BY). The use, distribution or repro-
duction in other forums is permitted, pro-
vided the original author(s) or licensor
are credited and that the original publica-
tion in this journal is cited, in accordance
with accepted academic practice. No use,
distribution or reproduction is permitted
which does not comply with these terms.
www.frontiersin.org August 2013 | Volume 4 | Article 258 | 9
